Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Klumper, E."'
Autor:
Marabelle, A. *, Andtbacka, R., Harrington, K., Melero, I., Leidner, R., de Baere, T., Robert, C., Ascierto, P.A., Baurain, J -F, Imperiale, M., Rahimian, S., Tersago, D., Klumper, E., Hendriks, M., Kumar, R., Stern, M., Öhrling, K., Massacesi, C., Tchakov, I., Tse, A., Douillard, J -Y, Tabernero, J., Haanen, J., Brody, J.
Publikováno v:
In Annals of Oncology November 2018 29(11):2163-2174
Publikováno v:
In Value in Health October-November 2017 20(9):A743-A743
Autor:
Chowdhury, S., Birtle, A.J., Bjartell, A., Costa, L.A.M., Feyerabend, S., Galli, L., Kalinka-Warzocha, E., Kramer, G., Rey, J.P. Maroto, Lumen, N., Matveev, V.B., Paiss, T., Spaeth, D., Antoni, L., Klumper, E., Wapenaar, R., Lee, E.
Publikováno v:
In Annals of Oncology 1 October 2016 27 Supplement 6:vi253-vi253
Autor:
Chowdhury, S, Birtle, A, Bjartell, A, Costa, L, Feyerabend, S, Galli, L, Lumen, N, Kalinka-Warzocha, E, Maroto, P, Matveev, V, Paiss, T, Spaeth, D, Dearden, L, Klumper, E, Thingstad, T, Wapenaar, R, Lee, E
Publikováno v:
In Value in Health November 2015 18(7):A482-A482
Autor:
Klumper E, Giaccone G, Pieters R, Broekema G, van Ark-Otte J, Er, Wering, Gj, Kaspers, Anjo JP Veerman
Publikováno v:
Europe PubMed Central
Previously, we showed that in vitro resistance to daunorubicin (DNR) at initial diagnosis was related to a poor long-term clinical outcome in childhood acute lymphoblastic leukemia (ALL), and that cells of relapsed ALL were in vitro more resistant to
Autor:
Gertjan Kaspers, Kardos, G., Pieters, R., Zantwijk, C. H., Klumper, E., Hählen, K., Waal, F. C., Wering, E. R., Veerman, A. J. P.
Publikováno v:
Leukemia, 8(7), 1224-1229. Nature Publishing Group
Scopus-Elsevier
Kaspers, G J L, Kardos, G, Pieters, R, Van Zantwijk, C H, Klumper, E, Hählen, K, De Waal, F C, Van Wering, E R & Veerman, A J P 1994, ' Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia : A preliminary report ', Leukemia, vol. 8, no. 7, pp. 1224-1229 .
Scopus-Elsevier
Kaspers, G J L, Kardos, G, Pieters, R, Van Zantwijk, C H, Klumper, E, Hählen, K, De Waal, F C, Van Wering, E R & Veerman, A J P 1994, ' Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia : A preliminary report ', Leukemia, vol. 8, no. 7, pp. 1224-1229 .
The better prognosis of acute lymphoblastic leukemia (ALL) than of acute non-lymphoblastic leukemia (ANLL) in children, and the often observed better prognosis of myeloid-antigen (MyAg) negative ALL than of MyAg-positive ALL, may be related to differ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::bd15cc651f4e00c8644015c377f39e49
https://research.vumc.nl/en/publications/9accc758-cd4a-4417-80ed-5c577094b20a
https://research.vumc.nl/en/publications/9accc758-cd4a-4417-80ed-5c577094b20a
Publikováno v:
Europe PubMed Central
Autor:
Gl, Kaspers, Anjo JP Veerman, Pieters R, van Zantwijk I, Klumper E, Hählen K, Fc, Waal, Er, Wering
Publikováno v:
Europe PubMed Central
Mitoxantrone (MIT) has not been studied as a single agent in children with untreated leukemia. The antileukemic activity of MIT in these patients and its activity in relation to clinical and cell biological features is unknown. We studied the in vitr
Autor:
Pieters, R., Kaspers, G. J.L., Klumper, E., Van Wering, E. R., Van Der Does-Van Den Berg, A., Veerman, A. J.P.
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde, 138(14), 706-712. Bohn Stafleu van Loghum
Pieters, R, Kaspers, G J L, Klumper, E, Van Wering, E R, Van Der Does-Van Den Berg, A & Veerman, A J P 1994, ' KLINISCHE RELEVANTIE VAN RESISTENTIE TEGEN CYTOSTATICA BIJ KINDEREN MET LEUKEMIE ', Nederlands Tijdschrift voor Geneeskunde, vol. 138, no. 14, pp. 706-712 .
Pieters, R, Kaspers, G J L, Klumper, E, Van Wering, E R, Van Der Does-Van Den Berg, A & Veerman, A J P 1994, ' KLINISCHE RELEVANTIE VAN RESISTENTIE TEGEN CYTOSTATICA BIJ KINDEREN MET LEUKEMIE ', Nederlands Tijdschrift voor Geneeskunde, vol. 138, no. 14, pp. 706-712 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::98319a2eec1ea0b708d4d1ac7e60d199
https://research.vumc.nl/en/publications/df3074bb-ccbd-4857-89ca-616e515ab6c3
https://research.vumc.nl/en/publications/df3074bb-ccbd-4857-89ca-616e515ab6c3
Publikováno v:
Kaspers, G J L, Pieters, R, Klumper, E, De Waal, F C & Veerman, A J P 1993, ' DE BEHANDELING VAN EEN RECIDIEF BIJ KINDEREN MET ACUTE LYMFATISCHE LEUKEMIE. HUIDIGE RESULTATEN EN ENKELE ONTWIKKELINGEN ', Tijdschrift voor Kindergeneeskunde, vol. 61, no. 1, pp. 1-7 .
The results of current treatment of relapsed childhood acute lymphoblastic leukemia (ALL) are discussed, together with some recent developments which (might) influence such treatment. At present more than 95% of children with ALL will achieve a compl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10172::7750f64bcafdeddbdc350e23db81823f
https://research.vumc.nl/en/publications/e845f2e2-bd12-4350-9384-77fcd7153a61
https://research.vumc.nl/en/publications/e845f2e2-bd12-4350-9384-77fcd7153a61